Is there a difference in the incidence of metastasis at diagnosis of lung cancer between smokers and non smokers? Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013
Screening for lung cancer: who should (not) be enrolled? Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening? Year: 2019
Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening? Source: ERJ Open Res, 4 (3) 00001-2018; 10.1183/23120541.00001-2018 Year: 2018
Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Bronchoscopy - any use for follow-up of operated lung cancer (LC) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001
Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016
Comparative analysis of lung tuberculosis (LTB) and lung cancer (LC) patients‘ smoking habits Source: Eur Respir J 2004; 24: Suppl. 48, 151s Year: 2004
Screening for incidence of lung cancer (LC) among the patients with pulmonary pathology (with special reference to histological subtype and TNM-staging system) in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 537s Year: 2005
Resectable proportion of lung cancers in an unselected population Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Determinants of smoking status of patients with lung or head and neck cancer, at diagnosis and one year after Source: International Congress 2017 – Smoking and health hazards Year: 2017
Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC) Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Association between young age and genomic alterations in never-smoker patients with non–small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
Screening and diagnosis of lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013
Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up? Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020 Year: 2020
Prevalence of preinvasive bronchial lesions in patients with lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013
Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Screening for lung cancer Source: Eur Respir Mon; 2009: 44: 57–70 Year: 2009
Primary adenocarcinoma of the lung in smokers and never smokers Source: Eur Respir J 2004; 24: Suppl. 48, 300s Year: 2004